Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
2020 · JAMA · 1,403 citations
https://doi.org/10.1001/jama.2020.12134
R
Ruben Smith
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
283
Papers
17.0K
Citations
60
h-index
130
i10-index
Ruben Smith is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Functional Brain Connectivity Studies. The author has an h-index of 60, co-authored 241 publications.
ORCID: 0000-0001-7147-0112Papers by this author
worksFour distinct trajectories of tau deposition identified in Alzheimer’s disease
2021 · Nature Medicine · 704 citations
https://doi.org/10.1038/s41591-021-01309-6
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
2021 · Brain · 532 citations
https://doi.org/10.1093/brain/awab223
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
2020 · Nature Communications · 521 citations
https://doi.org/10.1038/s41467-020-15701-2
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
2020 · Nature Communications · 521 citations
https://doi.org/10.1038/s41467-020-15701-2
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
2022 · Nature Medicine · 457 citations
https://doi.org/10.1038/s41591-022-02049-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat